NEW DELHI: Ranbaxy Laboratories chairman, CEO and MD Malvinder Mohan Singh stepped down on Sunday, within a year of the firm’s acquisition by Japanese giant Daiichi Sankyo, marking the end of the family’s long association.

Back Page

More In: NEW DELHI | NATIONAL